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Fibroblast growth factors (FGFs) constitute a family of at least 23 structurally
related heparin-binding proteins that are involved in regulation of cell growth,
survival, differentiation and migration. Sucrose octasulfate (SOS), a chemical
analogue of heparin, has been demonstrated to activate FGF signalling
pathways. The structure of rat FGF1 crystallized in the presence of SOS has
been determined at 2.2 A˚ resolution. SOS-mediated dimerization of FGF1 was
observed, which was further supported by gel-ﬁltration experiments. The major
contributors to the sulfate-binding sites in rat FGF1 are Lys113, Lys118, Arg122
and Lys128. An arginine at position 116 is a consensus residue in mammalian
FGF molecules; however, it is a serine in rat FGF1. This difference may be
important for SOS-mediated FGF1 dimerization in rat.
1. Introduction
Fibroblast growth factors (FGFs) constitute a large family of signal-
ling molecules that are involved in developmental processes, angio-
genesis and tumour growth. At the cellular level, FGFs play
important roles in cell differentiation, proliferation, migration and
survival (Powers et al., 2000; Ornitz & Itoh, 2001). The expression of
different FGFs varies from ubiquitous for FGF2 to highly restricted
for FGF4 (Basilico & Moscatelli, 1992). Mutations in FGFs or
inappropriate protein expression are correlated with various patho-
logical processes resulting in morphogenetic disorders and cancer
(Takahashi et al., 1992; Kornmann et al., 1997). FGFs signal by acti-
vating their speciﬁc cell-surface receptors (FGFRs). Vertebrates have
up to ﬁve FGFR paralogues (Powers et al., 2000; Sleeman et al., 2001).
The diverse activities of FGFs are mediated by four receptor tyrosine
kinases (FGFR1–FGFR4), each composed of an extracellular ligand-
binding domain consisting of three immunoglobulin-like modules
(Ig1–Ig3), a single transmembrane helix and a cytoplasmic part with
protein tyrosine kinase activity (Ornitz et al., 1996). For FGFRs 1–3,
alternative splicing of the Ig3 domain results in two isoforms (IIIb
and IIIc) with different ligand speciﬁcities. One receptor can bind and
become activated by several FGF ligands.
Receptor dimerization and binding of heparin or heparan sulfate
(HS) proteoglycans (HSPGs) are required for FGF signalling (Yayon
et al., 1991; Schlessinger, 2000). HS is produced in cells by modiﬁ-
cation of the initially synthesized polysaccharide backbone composed
of N-acetyl glucosamine and glucuronic acid disaccharide units
(Sugahara & Kitagawa, 2002). HS contains 40–300 saccharide units
that are modiﬁed by a range of enzymes, replacing N-acetyl with
N-sulfate, epimerizing glucuronic acid to iduronic acid and adding
sulfate groups to iduronic acid or sulfate groups to the O6 glucosa-
mine position. The ﬁnal versions of HS usually consist of regions of
up to 12–14 saccharide units with heavy modiﬁcations (NS domains),
separated by stretches of 14–18 saccharide units with low levels of
modiﬁcation (S domains). Heparin is a mast-cell-derived analogue of
HS that is more highly sulfated but with less complex sulfation
patterns. Heparin can replace HS in FGF cellular signalling when HS
has been removed by chlorate treatment. Hence, heparin has been
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used for indirect studies of the interactions of FGFs with HS (Ornitz
et al., 1992; Walker et al., 1994). Variations in the distribution of basic
amino acids on the surface of FGFs result in FGF speciﬁcity towards
different HS sulfate groups (Raman et al., 2003).
Two contrasting models, symmetric and asymmetric, for FGFR
dimerization have been proposed based on the crystal structures of
FGF–FGFR–heparin complexes. In the symmetric model, two 1:1:1
FGF2–FGFR1–heparin complexes form a symmetric dimer (Plot-
nikov et al., 1999; Ponting & Russell, 2000; Schlessinger et al., 2000).
Each FGF molecule is monomeric and binds to both receptor
molecules in the dimer; direct contacts occurs between the two
FGFRs. In the complex, heparin binds to both the two FGFs and the
two FGFRs, thereby enhancing FGF–FGFR afﬁnity. In the asym-
metric model derived from the FGF1–FGFR2–heparin structure, a
single heparin oligosaccharide bridges two FGF molecules (forming a
FGF–heparin–FGF complex with direct FGF–FGF interactions) that
in turn facilitate dimerization of the receptor (Pellegrini et al., 2000).
Heparin binds only to one receptor molecule, resulting in asymmetry
of the dimer. Unlike the conﬁguration in the symmetric model, each
FGF molecule contacts a single molecule of the receptor and no
direct FGFR–FGFR contacts are observed. The total lack of a
protein–protein interface between the two FGF–FGFR dimer
complexes makes heparin necessary for receptor dimerization in the
asymmetric model.
In addition to heparin, a number of chemically diverse low-
molecular-weight and sulfated saccharides, such as sucrose octa-
sulfate (SOS), have been reported to potentiate FGF activity. SOS
has been shown to mimic heparin action in supporting FGF-induced
neoangiogenesis and cell proliferation in vitro (Folkman et al., 1991;
Arunkumar et al., 2002; Loughman et al., 1996; Yeh et al., 2002).
Moreover, SOS facilitates wound healing by enhancing FGF-induced
angiogenesis (Rashid et al., 1999). The molecular mechanism by
which SOS stimulates FGF signalling is not fully understood. It has
been demonstrated that SOS induces FGF–FGFR dimerization in
vitro. The crystal structure of the human dimeric FGF–FGFR–SOS
complex has also been published (Yeh et al., 2002) and analysis of this
dimeric structure reveals that SOS induces FGF–FGFR dimerization
in a similar manner to the symmetric model. In accordance, the
bovine FGF1–SOS crystal structure shows the presence of only one
SOS molecule bound to the high-afﬁnity heparin-binding site of one
FGF1 molecule and thus does not indicate SOS-mediated FGF1
dimerization (Zhu et al., 1993).
Here, we present the gel-ﬁltration analysis and the crystal structure
of rat FGF1 in complex with SOS, showing that rat FGF1 forms a
SOS-mediated dimer in solution as well as in crystals. The inter-
actions of SOS with FGF1 have been compared with those observed
in the bovine complex, revealing new features of SOS binding.
2. Materials and methods
A cDNA fragment encoding rat FGF1 (residues 22–155; Swiss-Prot
P61149) was synthesized by polymerase chain reaction using Quick-
Clone Rat Brain cDNA (BD Biosciences). The ampliﬁed cDNA
fragment was subcloned into the EcoRI/HindIII cloning site of the
pQE-60 plasmid (Qiagen). Escherichia coli strain Top10F0 (Invi-
trogen) was used for transformation. Expression of the protein was
induced by adding isopropyl -d-1-thiogalactopyranoside (IPTG;
Sigma). The protein was puriﬁed by afﬁnity chromatography using a
5 ml HiTrap Heparin HP column (GE Healthcare).
Protein crystallization was performed in hanging-drop vapour-
diffusion experiments by mixing 1 ml protein solution (1 mM rat
FGF1 solution containing 0.5–1 mM SOS) and 1 ml reservoir solution
(10% PEG 6000, 0.1M citric acid pH 5.0). Crystals were obtained at
room temperature within 2 d. X-ray data were collected at 100 K
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Table 1
Data-collection and processing statistics for the rat FGF1–SOS–FGF1 complex.
Values in parentheses are for the highest resolution shell.
X-ray source BW7A, EMBL, Hamburg
Wavelength (A˚) 0.8142
Space group P21
Unit-cell parameters
a (A˚) 36.88
b (A˚) 52.78
c (A˚) 73.13
 () 97.43
Mosaicity () 0.7
Resolution (A˚) 40.8–2.2 (2.32–2.20)
No. of observations 41588
No. of unique reﬂections 12293
Redundancy 3.4
Completeness (%) 98.4 (98.2)
hI/(I)i 16.7 (7.0)
Rmerge† (%) 5.1 (19.2)
VM (A˚
3 Da1) 2.39
Reﬁnement
Protein atoms 2143
Protein residues
Chain A 7–138
Chain B 8–138
Other atoms 163 waters, 1 sucrose octasulfate (55 atoms)
Rwork‡ (%) 20.6
Rfree§ (%) 27.7
Mean B values (A˚2)
Molecule A
Main chain 15.3
Side chain 23.0
Molecule B
Main chain 22.7
Side chain 27.4
Water atoms 25.6
Sucrose octasulfate atoms 20.0
R.m.s.d. bond lengths (A˚) 0.022
R.m.s.d. bond angles () 1.5
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of
an individual measurement of the reﬂection with Miller indices hkl and hI(hkl)i is the
mean intensity of that reﬂection. ‡ Rwork =
P
hkl

jFo;hkl j  jFc;hkl j

=
P jFo;hkl j, where
|Fo,hkl| and |Fc,hkl| are the observed and calculated structure-factor amplitudes,
respectively. § Rfree is equivalent to Rwork, but calculated with reﬂections omitted
from the reﬁnement process (5% of reﬂections were omitted).
Figure 1
The rat FGF1–SOS–FGF1 ternary complex observed in the crystal structure. Both
direct and SOS-mediated FGF1–FGF1 interactions are observed. A 2Fo  Fc
electron-density map around SOS contoured at 1 is shown in grey.
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from a cryoprotected crystal (reservoir solution containing 20%
glycerol) using synchrotron radiation (BW7A, EMBL, Hamburg).
The data were indexed, integrated and scaled using the programs
MOSFLM and SCALA (Collaborative Computational Project,
Number 4, 1994). Crystal data and data-collection statistics are listed
in Table 1.
The FGF1–SOS structure was determined by the molecular-
replacement method using the program Phaser (Storoni et al., 2004).
A crystal structure of rat FGF1 (molecule A, PDB code 2j3p; Kulahin
et al., 2007) was used as a search model and solutions accounting for
the two molecules in the asymmetric unit were obtained. Subse-
quently, automated model building was performed using the program
ARP/wARP (Perrakis et al., 1999). This resulted in the tracing of 95%
of the residues. The missing residues were inserted manually using the
program Coot (Emsley & Cowtan, 2004). Structure reﬁnement was
performed with the program REFMAC5 (Murshudov et al., 1999).
Water molecules and a single SOS molecule were gradually intro-
duced into the structure. The quality of the structure was evaluated
using the program PROCHECK (Laskowski et al., 1993). Figures
were prepared using the program PyMOL (DeLano, 2002).
Gel-ﬁltration experiments were performed either in phosphate-
buffered saline (PBS) or in PBS with 0.0362 mM SOS using a
Superdex 75 column (GE Healthcare).
3. Results
3.1. Structure of the rat FGF1–SOS–FGF1 complex
The rat FGF1–SOS crystals contain two FGF1 molecules and one
SOS molecule in the asymmetric unit (Fig. 1). Comparison of the
present FGF1–SOS structure with that of rat FGF1 alone (Kulahin et
al., 2007) revealed that FGF1 adopts the same conformation in both
structures, with an overall r.m.s.d. of 0.83 A˚ on 129 C atoms.
SOS interacts with both FGF1 molecules in the asymmetric unit.
The interaction area comprises both protein–protein and protein–
SOS–protein contacts. The interactions in the crystal were analyzed
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Figure 2
(a) Ligplot showing interactions in the FGF1–SOS–FGF1 ternary complex. The interactions are dominated by salt bridges. (b) Stereo plot of a superposition of rat FGF1–
SOS–FGF1 (blue C atoms) and bovine FGF1–SOS (greenC atoms). Only residues within 5 A˚ from SOS are included and interacting basic residues are labelled.
Files: f/fw5175/fw5175.3d f/fw5175/fw5175.sgml FW5175 PC IU-0813/33(18)4 813/31(18)4 () FW5175 PROOFS F:PC:2008:64:5:0:0–0
using the PISA server (Krissinel & Henrick, 2007). The FGF1(A)–
SOS–FGF1(B) complex observed in the crystal is classiﬁed as a
possible solution multimer, with a total buried accessible surface area
of 1500 A˚2. Two additional minor FGF1–FGF1 crystal contact areas
of 1180 and 960 A˚2 were found.
Direct hydrogen-bonding interactions between the two FGF1
molecules and the highly charged SOS molecule are shown sche-
matically in Fig. 2(a), which was generated with the programs
LIGPLOT (Wallace et al., 1995) and HBPLUS (McDonald &
Thornton, 1994). A total of 11 residues make interactions with seven
of the eight sulfate groups of SOS. Seven of the 11 interacting resi-
dues are basic: three and four from the A and B chains, respectively.
This suggests that SOS invokes strong electrostatic interactions
within the ternary FGF1–SOS–FGF1 complex.
3.2. Gel filtration of rat FGF1 in the presence of SOS
Gel ﬁltration of rat FGF1 produced a single symmetrical peak
corresponding to the monomeric form of the protein (Fig. 3; red
colour). When the gel-ﬁltration column was pre-equilibrated with
SOS-containing buffer (2:1 FGF1:SOS molar ratio), FGF1 was eluted
as a single peak with the elution volume reduced by 7 ml, corre-
sponding to the dimeric form of the protein (Fig. 3; blue colour).
4. Discussion
The present study was undertaken to investigate if and how rat FGF1
interacts with the heparin mimic SOS. From gel-ﬁltration experi-
ments, we estimated the molar weight of rat FGF1 to be 13 kDa
(Fig. 3), compared with the calculated value of 17.4 kDa. After the
addition of SOS (MW ’ 1.1 kDa) to a 2:1 FGF1:SOS molar ratio, a
single peak corresponding to a molar weight of 22 kDa was observed.
Even though rat FGF1 runs more slowly than expected, the experi-
ment clearly suggests that a ternary FGF1–SOS–FGF1 complex is
formed in solution.
The existence of the FGF1(A)–SOS–FGF1(B) ternary complex
was conﬁrmed by X-ray crystallography. A similar ternary complex
was not observed in the bovine FGF1–SOS structure (Zhu et al.,
1993). Superimposition of the rat FGF1–SOS–FGF1 complex and the
bovine FGF1–SOS complex reveals that the binding modes are quite
different (Fig. 2b) and that only two of the sulfates occupy similar
positions. In the rat structure, the SOS furanose ring approximately
occupies the position of the pyranose ring of the bovine complex. The
residues forming the major sulfate-binding sites in bovine FGF1 are
Arg116, Lys118 and Arg122. Interestingly, whereas arginine is the
consensus residue at this position in mammalian FGF molecules, it is
a serine in rat FGF1. Instead, the major contributors to the sulfate-
binding sites in rat FGF1 are Lys113, Lys118, Arg122 and Lys128.
This difference might explain why SOS-mediated FGF1 dimerization
is seen in rat and suggests that SOS functions differently in rats and
cattle. A further consequence of SOS-mediated FGF1 dimerization in
rat is that it suggests that SOS-induced activation of rat FGFR follows
the asymmetric model.
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Figure 3
Gel-ﬁltration analysis, demonstrating the dimerization effect of SOS on rat FGF1 in
solution. Gel-ﬁltration experiments were performed either in PBS (peak shown in
red) or in PBS with 0.0362 mM SOS (peak shown in blue) using a Superdex 75
column. Elution peaks corresponding to aprotinin (6.5 kDa), ribonuclease A
(13.7 kDa), carbonic anhydrase (29 kDa), ovalbumin (43 kDa), conalbumin
(75 kDa) and blue dextran (void volume) are shown in black.
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